Samuel Bitoun - Concepedia

Author

Samuel Bitoun

Inserm ORCID

Also Known As

Alexandre Belot, Aurélia Bisson-Vaivre, Bitoun, S, Bitoun, Samuel, Julien ZUBER, S Bitoun, S. Bitoun, Samuel Bitoun

Publications

736

Citations

H-Index

Concepts

All Affiliations

Inserm Bicêtre Hospital Assistance Publique – Hôpitaux de Paris Université Paris-Saclay Commissariat à l'Énergie Atomique et aux Énergies Alternatives

About

Samuel Bitoun is an author at Inserm specializing in oxidative stress, metabolism, and neuroprotection.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	72
2	Medicine	1	1	72
3	Metabolism	1	1	72
4	Pharmacology	1	1	72
5	Oxidative Stress	1	1	72

Samuel Bitoun

Publications

515

Citations

H-Index

Page 1

	Year	Citations
Treatment of neurosarcoidosis Samuel Bitoun, Diane Bouvry, Raphaël Borie, Neurology	2016	101
Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease Diana E. Matei, Madhvi Menon, Dagmar Alber, Med	2021	99
Rituximab Impairs B Cell Response But Not T Cell Response to <scp>COVID</scp>‐19 Vaccine in Autoimmune Diseases Samuel Bitoun, Julien Henry, Delphine Desjardins, Arthritis & Rheumatology	2021	74
Melatonin treatment protects liver of Zucker rats after ischemia/reperfusion by diminishing oxidative stress and apoptosis Roman Kireev, Samuel Bitoun, Sara Cuesta‐Sancho, European Journal of Pharmacology Zucker RatsMelatonin TreatmentReperfusion InjuryMedicineLiver Physiology	2012	72
Methotrexate and BAFF interaction prevents immunization against TNF inhibitors Samuel Bitoun, Gaëtane Nocturne, Bineta Ly, Annals of the Rheumatic Diseases	2018	30
Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies Samuel Bitoun, Signe Hässler, David Ternant, JAMA Network Open	2023	27
Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis Julien Duquesne, Vincent Bouget, Paul-Henry Cournède, Lara D. Veeken	2022	26
Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts Vincent Bouget, Julien Duquesne, Signe Hässler, RMD Open	2022	25
Pegylation Reduces the Uptake of Certolizumab Pegol by Dendritic Cells and Epitope Presentation to T-Cells Marie de Bourayne, Sylvain Meunier, Samuel Bitoun, Frontiers in Immunology	2022	20
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer. E. Sebbag, Kim Lauper, J. Molina Collada, PubMed	2024	17

Page 1